Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN
· Real-Time Price · USD
8.46
0.25 (3.05%)
At close: May 23, 2025, 3:59 PM
8.01
-5.32%
After-hours: May 23, 2025, 04:05 PM EDT
Addex Therapeutics Ltd Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Research Revenue | 1.6M | 1.4M | 2.9M |
| Research Revenue Growth | +14.29% | -51.72% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 337.25K | 507.17K | 774.94K | 1.7M | 1.75M | 1.95M | 1.8M | -240.68K | 2.39M | 1.53M | 2.24M | 497.58K | 1.47M | 1.85M | 1.32M | 637.05K | 1.28M | 1.59M | 1.53M | -799.34K | 1.77M | 1.48M | 1.5M | 1.33M | 1.19M | 412.83K | 412.83K | 137.66K | 137.66K | 415.37K | 415.37K | 187.26K | 187.26K | 352.7K | 352.7K | 465.88K | 465.88K | 360.51K | 360.51K |
| Selling, General, and Administrative Revenue Growth | -33.50% | -34.55% | -54.51% | -2.65% | -10.25% | +8.23% | -848.51% | -110.07% | +56.06% | -31.66% | +350.40% | -66.18% | -20.33% | +39.65% | +107.58% | -50.20% | -19.40% | +3.75% | -291.40% | -145.25% | +19.46% | -1.36% | +13.10% | +11.25% | +188.60% | 0.00% | +199.89% | 0.00% | -66.86% | 0.00% | +121.81% | 0.00% | -46.91% | 0.00% | -24.29% | 0.00% | +29.23% | 0.00% | n/a |
| Research and Development Revenue | 77.85K | 184.46K | 245.13K | 454.31K | 833.48K | 751.86K | 708.78K | 5.74M | 1.74M | 5.75M | 3.77M | 3.5M | 2.86M | 3.73M | 2.75M | 5.06M | 1.17M | 2.32M | 2.81M | 5.87M | 2.17M | 3.41M | 1.8M | 1.42M | 1.42M | 1.04M | 1.04M | 740.52K | 740.52K | 573.93K | 573.93K | 700.45K | 700.45K | 530.26K | 530.26K | 415.28K | 415.28K | 474.4K | 474.4K |
| Research and Development Revenue Growth | -57.80% | -24.75% | -46.04% | -45.49% | +10.86% | +6.08% | -87.66% | +230.51% | -69.76% | +52.63% | +7.63% | +22.22% | -23.30% | +35.80% | -45.72% | +333.73% | -49.67% | -17.37% | -52.15% | +170.43% | -36.41% | +89.50% | +26.99% | 0.00% | +36.04% | 0.00% | +40.70% | 0.00% | +29.03% | 0.00% | -18.06% | 0.00% | +32.09% | 0.00% | +27.69% | 0.00% | -12.46% | 0.00% | n/a |